Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |